Alaunos is a clinical stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. With our robust and innovative discovery engine, we strike cancer at its core by engineering cell therapies that target neoantigens arising from genomic mutations. We have developed proprietary, rapid, cost-effective solutions to deliver tumor-specific killer T cells to large cancer patient populations with unmet clinical need.
We are based in Houston, TX, home to the largest medical center in the world; and in a state with no state income tax and a low cost of living. For more information about Alaunos, please visit www.alaunos.com. Click on the Careers tab of our web page to join our exciting team and help make a difference in the lives of cancer patients and their families.
Company Details
- Employees
- 10
- Address
- 8030 El Rio St, Houston,texas 77054,united States
- Industry
- Biotechnology
- Website
- https://alaunos.com
- Keywords
- Biotechnology Research.
- HQ
- Houston, Texas
Alaunos Therapeutics Questions
Alaunos Therapeutics's website is https://alaunos.com
Alaunos Therapeutics's LinkedIn profile is https://www.linkedin.com/company/alaunos
Alaunos Therapeutics has
10 employees.
View email and phone details for 10
employees at Alaunos Therapeutics.
Alaunos Therapeutics's industry is
Biotechnology
Alaunos Therapeutics's top competitors are
Celltex Therapeutics Corporation,
Tvardi Therapeutics,
Moleculin Biotech, Inc.,
Bellicum Pharmaceuticals, Inc.,
Kiromic Biopharma, Inc.,
Cellipont Bioservices,
Immatics,
Avance Biosciences, Inc.,
Ingeneron,
Marker Therapeutics, Inc..
Alaunos Therapeutics's categories are Biotechnology
